Canada to review Moderna’s COVID-19 vaccine candidate in real time
Health Canada will collect data from a late stage clinical trial of Moderna’s COVID-19 vaccine candidate in real time, a process that can expeditereviews of a drug compared to evaluating a larger quantity of data once a trial is complete in its entirety. The agency is doing the same with data from BioNTech/Pfizer’s candidate, as well as AstraZeneca’s. Moderna’s CEO recently indicated he expects their candidate to be in a position to seek Emergency Use Authorization (EUA) in the United States by late November, as documented in earlier COVID-19 DEW Reports.
Published: October 13, 2020